These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28408813)

  • 1. COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).
    Parrón Collar D; Pazos Guerra M; Rodriguez P; Gotera C; Mahíllo-Fernández I; Peces-Barba G; Seijo LM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1033-1038. PubMed ID: 28408813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of combined pulmonary fibrosis and chronic obstructive pulmonary disease on long-term survival after lung cancer surgery.
    Sekine Y; Sakairi Y; Yoshino M; Koh E; Hata A; Suzuki H; Yoshino I
    Thorac Cardiovasc Surg; 2014 Jun; 62(4):332-7. PubMed ID: 24879070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
    Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.
    Almagro P; Lapuente A; Pareja J; Yun S; Garcia ME; Padilla F; Heredia JL; De la Sierra A; Soriano JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1353-61. PubMed ID: 26213464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of tuberculosis in COPD.
    Yakar HI; Gunen H; Pehlivan E; Aydogan S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():323-329. PubMed ID: 28176901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of chronic obstructive pulmonary disease and its relationship to lung cancer prognosis after surgical resection.
    Sekine Y; Suzuki H; Yamada Y; Koh E; Yoshino I
    Thorac Cardiovasc Surg; 2013 Mar; 61(2):124-30. PubMed ID: 22535670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of restrictive versus obstructive pulmonary function patterns on mortality in patients undergoing transcatheter aortic valve implantation.
    Escárcega RO; Torguson R; Tavil-Shatelyan A; Daoud Y; Koifman E; Kiramijyan S; Gai J; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2016; 17(3):181-5. PubMed ID: 26997471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized pulmonary rehabilitation and occupational therapy based on cardiopulmonary exercise testing for patients with advanced chronic obstructive pulmonary disease.
    Maekura R; Hiraga T; Miki K; Kitada S; Miki M; Yoshimura K; Yamamoto H; Kawabe T; Mori M
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1787-800. PubMed ID: 26366071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.
    Andersen KH; Iversen M; Kjaergaard J; Mortensen J; Nielsen-Kudsk JE; Bendstrup E; Videbaek R; Carlsen J
    J Heart Lung Transplant; 2012 Apr; 31(4):373-80. PubMed ID: 22226804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of undiagnosed and undertreated chronic obstructive pulmonary disease in lung cancer population.
    Zhang J; Zhou JB; Lin XF; Wang Q; Bai CX; Hong QY
    Respirology; 2013 Feb; 18(2):297-302. PubMed ID: 23051099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 19. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes.
    Camillo CA; Langer D; Osadnik CR; Pancini L; Demeyer H; Burtin C; Gosselink R; Decramer M; Janssens W; Troosters T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2671-2679. PubMed ID: 27822029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.
    Qin J; Li G; Zhou J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1515-20. PubMed ID: 27445471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.